Citation: Ra. Gabel et al., IN-VIVO PHARMACOLOGY OF L-159,913, A NEW HIGHLY POTENT AND SELECTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, Clinical and experimental hypertension, 17(6), 1995, pp. 931-953
Authors:
KIVLIGHN SD
ZINGARO GJ
GABEL RA
BROTEN TP
SCHORN TW
SCHAFFER LW
NAYLOR EM
CHAKRAVARTY PK
PATCHETT AA
GREENLEE WJ
SIEGL PKS
Citation: Sd. Kivlighn et al., IN-VIVO PHARMACOLOGY OF A NOVEL AT(1) SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST, MK-996, American journal of hypertension, 8(1), 1995, pp. 58-66
Authors:
DUGGAN ME
NAYLOROLSEN AM
PERKINS JJ
ANDERSON PS
CHANG CTC
COOK JJ
GOULD RJ
IHLE NC
HARTMAN GD
LYNCH JJ
LYNCH RJ
MANNO PD
SCHAFFER LW
SMITH RL
Citation: Me. Duggan et al., NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS .7. DESIGN AND SYNTHESIS OF A POTENT, ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 38(17), 1995, pp. 3332-3341
Citation: Ll. Chang et al., TRIAZOLINONES AS NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS .2. DISCOVERY OF A POTENT AND ORALLY-ACTIVE TRIAZOLINONE ACYLSULFONAMIDE, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 115-120
Authors:
SIEGL PKS
GABEL RA
ZINGARO GJ
SCHORN T
HARVEY C
ARBEGAST P
BROTEN TP
SCHAFFER LW
CHAKRAVARTY PK
GREENLEE W
NAVLOR E
PATCHETT AA
KIVLIGHN SD
Citation: Pks. Siegl et al., IN-VIVO PHARMACOLOGY AND ANTIHYPERTENSIVE ACTIVITY OF L-159,282 (MK-996) A NONPEPTIDE ANGIOTENSIN-II (A-II) RECEPTOR ANTAGONIST, The FASEB journal, 8(5), 1994, pp. 10000881-10000881
Authors:
CHAKRAVARTY PK
NAYLOR EM
CHEN A
CHANG RSL
CHEN TB
FAUST KA
LOTTI VJ
KIVLIGHN SD
GABLE RA
ZINGARO GJ
SCHORN TW
SCHAFFER LW
BROTEN TP
SIEGL PKS
PATCHETT AA
GREENLEE WJ
Citation: Pk. Chakravarty et al., A HIGHLY POTENT, ORALLY-ACTIVE IMIDAZO[4,5-B]PYRIDINE BIPHENYLACYLSULFONAMIDE (MK-996-L-159,282) - A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 37(24), 1994, pp. 4068-4072
Authors:
SCHAFFER LW
DAVIDSON JT
SIEGL PKS
GOULD RJ
NUTT RF
BRADY SF
CONNOLLY TM
Citation: Lw. Schaffer et al., RECOMBINANT LEECH ANTIPLATELET PROTEIN PREVENTS COLLAGEN-MEDIATED PLATELET-AGGREGATION BUT NOT COLLAGEN GRAFT THROMBOSIS IN BABOONS, Arteriosclerosis and thrombosis, 13(11), 1993, pp. 1593-1601
Citation: Cm. Harvey et al., ABBREVIATED THERAPY WITH THE SELECTIVE FACTOR-XA INHIBITOR, RECOMBINANT TICK ANTICOAGULANT PEPTIDE (RTAP), PROVIDES SUSTAINED ANTITHROMBOTIC EFFICACY IN A BABOON MODEL OF VASCULAR GRAFT THROMBOSIS, Thrombosis and haemostasis, 69(6), 1993, pp. 569-569
Authors:
SCHAFFER LW
DAVIDSON JT
CONNOLLY TM
GOULD RJ
NUTT RF
BRADY SF
SIEGL PKS
Citation: Lw. Schaffer et al., EFFECTS OF RECOMBINANT LEECH ANTIPLATELET PROTEIN (RLAPP), A SPECIFICINHIBITOR OF COLLAGEN-MEDIATED PLATELET-AGGREGATION, ON VASCULAR GRAFT THROMBOSIS IN ANESTHETIZED BABOONS, Thrombosis and haemostasis, 69(6), 1993, pp. 586-586